SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  FORM 10-Q/A
                                  AMENDMENT #1
================================================================================

(Mark One)
    X      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
   ---     EXCHANGE ACT OF 1934
   
           For the quarterly period ended April 1, 1994

                                 OR

   [_]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
           EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ________________
           TO ___________________________


Commission File No.0-12744


                              SUNRISE MEDICAL INC.
             (Exact name of registrant as specified in its charter)

         Delaware                                                  95-3836867
(State or other jurisdiction of                               (I.R.S. Employer
incorporation or organization)                               Identification No.)


                        2382 FARADAY AVENUE, SUITE 200
                              CARLSBAD, CA  92008
                    (Address of principal executive offices)

       Registrant's telephone number, including area code: (619) 930-1500



Indicate by check mark whether registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months and (2) has been subject to such filing requirements for
the past 90 days.  Yes  X     No
                      -----      -----


Number of shares of common stock outstanding at May 6, 1994:  17,987,620


                                 SUNRISE MEDICAL INC.

PART 1--FINANCIAL INFORMATION
    
The company has restated previously issued financial results for the fiscal
years ended June 30, 1995 and July 1, 1994 following an internal investigation
that determined that accounting and financial reporting practices at its Bio
Clinic subsidiary were erroneous in numerous respects, resulting in the
overstatement of revenue, income and assets and the understatement of
liabilities. Because it is not practicable to reconstruct reliable accounting
records at Bio Clinic for interim periods during those years, the company has
been unable to allocate accurately to individual quarters the full-year
restatement adjustments for any financial statement item other than net sales.
Accordingly, the company has withdrawn its previously reported quarterly results
for the thirteen-week and thirty-nine week periods ended April 1, 1994, and
these previously reported results should be disregarded. Reference is made to
the company's Form 10-K/A Amendment No. 1 to Annual Report for the fiscal year
ended June 30, 1995 for additional information.     

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                            SUNRISE MEDICAL INC.


                                               
Date: February 21, 1996                     Ted N. Tarbet     
                                            ----------------------------- 
                                            Ted N. Tarbet
                                            Senior Vice President and
                                            Chief Financial Officer
                                            (Principal Financial Officer)


                                               
Date: February 21, 1996                     John M. Radak     
                                            ----------------------------- 
                                            John M. Radak
                                            Vice President and Controller
                                            (Principal Accounting Officer)

                                       2